Home›Stock Screener›Astec Lifesciences

Astec Lifesciences Share Price Today | Stock Price & Astec Lifesciences Share Screener

ASTEC Pesticides & Agrochemicals
Live Share Price NSE
₹712.70
▲ 4.10 (0.58%)
2026-10-05 00:00:00
Live Share Price BSE
₹712.65
▲ 3.85 (0.54%)
2026-10-05 00:00:00

As of October 5, 2026, the live Astec Lifesciences share price (NSE: ASTEC) is ₹712.70 on NSE and ₹712.65 on BSE, up 0.58% from the previous close, with shares trading between ₹700.00 and ₹721.75 in today's trading session, and a 52-week range of ₹521.85–₹918.75. Check ASTEC 52-week high low for the annual price range and momentum. Use the Astec Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Astec Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹84 and net income of ₹-19, an operating margin of -1.0% and a profit margin of -22.6%.

Astec Lifesciences Market Cap ₹1,588.10 Cr.
ASTEC P/E Ratio (TTM) -23.73
Astec Lifesciences P/B Ratio 4.04
EPS (TTM) ₹-37.79
Dividend Yield -
Debt to Equity 1.60
ASTEC 52 Week High ₹918.75
Astec Lifesciences 52 Week Low ₹521.85
Operating Margin -1.00%
Profit Margin -22.62%
ASTEC Revenue (TTM) ₹84.00
EBITDA -
Net Income ₹-19.00
Total Assets ₹942.00
Total Equity ₹391.00

Astec Lifesciences Share Price Chart

Track the current stock price of Astec Lifesciences with an interactive chart. Analyse ASTEC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Astec Lifesciences stock quote in one place.

The quote of ₹712.70 sits between the 52-week low of ₹521.85 and the 52-week high of ₹918.75, and the latest session moved 0.58% from the previous close.

Astec Lifesciences Company Profile - Fundamental Screener

Screen Astec Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTEC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Pesticides & Agrochemicals industry, and it trades under ISIN INE563J01010.

Company Details

Classification

Sector Chemicals
Industry Pesticides & Agrochemicals
Sub-Sector Pesticides & Agrochemicals
Segment E

Identifiers and Leadership

ISIN INE563J01010

Astec Lifesciences Balance Sheet Screener

Screen ASTEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹942, up from ₹881 in 2025.

Latest statistics put total assets at ₹942 and shareholder funds at ₹391, with a leverage ratio of 1.60.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 942 881 975 979 897 678 572 461 413 334
Current Assets 443 341 399 499 516 330 332 249 232 198
Fixed Assets 459 499 386 319 340 213 194 167 115 103

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 51 281 208 34 10 46 7 10 5 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 391 235 370 420 397 309 247 203 170 138
Share Capital 22 20 20 20 20 20 20 20 20 20
Reserves & Surplus 368 215 350 400 377 290 227 183 150 119

Astec Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen Astec Lifesciences income statement and profit fundamentals. Analyze ASTEC quarterly results. Astec Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹84 and net profit was ₹-19, equal to earnings per unit of ₹-8.40, at an operating margin of -1%.

In that period expenses were ₹84, interest cost ₹8 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹161 and net profit of ₹-8.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 84 161 126 75 92 120 96 101 70 156 52 112 145 130 121
Expenses 84 150 123 80 102 114 100 118 116 141 69 114 140 122 105

Operating Costs and Margins

EBITDA 0 12 3 -6 -11 6 -4 -18 -45 15 -17 -2 5 8 16
Operating Profit % -1.00% 6.00% 2.00% -9.00% -12.00% 5.00% -6.00% -20.00% -67.00% 8.00% -36.00% -3.00% 2.00% 4.00% 10.00%
Depreciation 11 12 11 10 12 12 11 12 9 9 9 9 9 8 9
Interest 8 8 7 8 11 10 10 9 7 7 6 6 7 6 6

Profit and Earnings

Profit Before Tax -19 -8 -16 -24 -33 -16 -25 -39 -62 -1 -32 -18 -11 -6 1
Tax 0 0 0 0 0 0 15 0 -22 0 -8 -4 -3 -1 0
Net Profit -19 -8 -16 -24 -33 -16 -40 -39 -40 -1 -24 -13 -8 -5 1
EPS -8.40 -3.48 -7.04 -11.35 -16.85 -8.20 -20.59 -19.66 -20.26 -0.50 -12.41 -6.85 -4.18 -2.54 0.43

Astec Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen ASTEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹81, and net cash flow was an inflow of ₹10.

Over the same period, investing activities used ₹4 and financing activities provided ₹95.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -81 -8 10 75 24 -8 168 15 65 19
Investing Activities -4 -15 -135 -113 -104 -73 -74 -53 -49 -18

Financing and Net Cash

Financing Activities 95 24 125 38 81 81 -95 37 -18 -1
Net Cash Flow 10 0 0 0 0 0 0 0 -3 1

Astec Lifesciences Shareholding Pattern Screener

See Astec Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Astec Lifesciences promoter holding and ownership changes for ASTEC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 71.96%, foreign institutions 0.01%, domestic institutions 3.33% and the public 20.48%, spread across 19,889 shareholders.

The shareholder count was 19,889 in 2026-Jun, compared with 21,041 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jul 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 71.96% 71.97% 71.97% 72.42% 72.42% 70.87% 70.87% 66.75%

Institutional Investors

FII Holding 0.01% 0.02% 0.04% 0.00% 0.02% 0.02% 0.25% 1.20%
DII Holding 3.33% 3.34% 3.17% 4.01% 4.01% 4.26% 4.34% 5.41%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.48% 20.81% 20.87% 19.32% 18.96% 19.98% 19.62% 20.71%
Other Holding 4.22% 3.86% 3.95% 4.25% 4.59% 4.87% 4.91% 5.93%
Shareholder Count 19,889 21,041 22,293 18,276 18,889 18,549 18,689 19,057

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Astec Lifesciences. Astec Lifesciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹1.50 0.14%
2022-March ₹1.50 0.11%
2021-March ₹1.50 0.09%
2020-March ₹1.50 0.15%
2019-March ₹1.50 0.39%
2018-March ₹1.50 0.28%
2017-March ₹1.50 0.26%

Astec Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include Astec Lifesciences stock. Check ASTEC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP

Astec Lifesciences Market Events Screener - Corporate Actions

Get Astec Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Astec Lifesciences stock events that may affect ASTEC share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated July 31, 2026, with a record date of July 31, 2026.

It is followed by Quarterly Result Announcement dated July 31, 2026 and Quarterly Result Announcement dated April 27, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-31 2026-07-31 Annual General Meeting NA -13.10%
2026-07-31 2026-07-31 Quarterly Result Announcement NA -8.33%
2026-04-27 2026-04-27 Quarterly Result Announcement NA -3.59%
2026-01-30 2026-01-30 Quarterly Result Announcement NA -12.93%
2025-10-29 2025-10-29 Quarterly Result Announcement NA -8.59%
2025-07-28 2025-07-28 Annual General Meeting NA 18.90%
2025-07-28 2025-07-28 Quarterly Result Announcement NA 0.28%
2025-07-04 2025-07-04 Rights 1:7 1.17%
2025-04-23 2025-04-23 Quarterly Result Announcement NA 8.19%
2025-01-27 2025-01-27 Quarterly Result Announcement NA -5.28%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -2.20%
2024-07-29 2024-07-29 Annual General Meeting NA -0.11%
2023-07-27 2023-07-27 Annual General Meeting NA -6.19%
2023-07-21 2023-07-22 Dividend ₹ 1.50 /share -2.96%
2022-07-19 2022-07-21 Dividend ₹ 1.50 /share 13.10%

Astec Lifesciences Competitors Screener - Peer Stocks Comparison

Screen ASTEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
UPL 42,420 18.96 52,502 11.41% 2,220 25.25
PI Industries 33,681 29.24 7,024 -15.59% 1,321 33.92
Sumitomo Chemical 20,700 35.94 3,385 3.56% 543 21.79
Bayer Crop Science 15,770 21.83 5,770 3.16% 689 14.19
Sharda Cropchem 6,497 10.23 5,410 23.53% 681 36.27
Dhanuka Agritech 4,045 14.00 2,071 15.49% 297 29.83
Rallis 3,834 31.33 2,631 6.54% 164 26.95
NACL Industries 3,052 246.60 1,587 27.74% 5 19.26
Bhagiradha Chemicals & Industries 2,971 110.87 538 19.68% 18 23.02
GSP Crop Science 2,128 21.46 1,531 17.66% 95 29.11

Astec Lifesciences Company Announcements - News & Reports Screener

Screen ASTEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 2, 2026 and September 29, 2026.

Date Update Actions
2026-10-02 Response To Volume Movement Letter -
2026-10-02 Clarification sought from Astec Lifesciences Ltd -
2026-09-29 Closure of Trading Window -
2026-09-18 Response To BSE Query Dated 18.09.2026 -
2026-09-18 Clarification sought from Astec Lifesciences Ltd -
2026-09-11 Response To BSE E-Mail Seeking Clarification On Price Movement -
2026-09-10 Clarification sought from Astec Lifesciences Ltd -
2026-09-09 Reply To BSE Query Regarding Volume Movement Dated September 9 2026 -
2026-09-09 Clarification sought from Astec Lifesciences Ltd -
2026-08-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-31 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-31 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-31 32Nd Annual General Meeting -
2026-07-31 32Nd Annual General Meeting -
2026-07-31 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-07-31 Financial Result For The Quarter Ended June 30 2026 -
2026-07-31 Board Meeting Outcome for Outcome Of Board Meeting -
2026-07-21 Board Meeting Intimation for Intimation Of Board Meeting -
2026-07-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹712.70, within a 52-week range of ₹521.85 to ₹918.75. The P/E ratio is -23.73 and the P/B ratio is 4.04, with earnings per unit of ₹-37.79. Market capitalisation stands at ₹1,588.10 Cr. The company operates in the Chemicals sector, in the Pesticides & Agrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.